Deep Vein Thrombosis

Advances in understanding pathogenic mechanisms of thrombophilic disorders
Venous thromboembolism is a major medical problem, annually affecting 1 in 1000 individuals.

Malmö, Sweden
Sweden
Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthrosc
BACKGROUND: Knee arthroscopy, the most common orthopedic operation worldwide, carries a definite risk for deep venous thrombosis; however, postsurgical thromboprophylaxis is not routinely recommended.

Padua, Italy
Italy
Venous thromboembolism during pregnancy
Venous thromboembolism is the leading cause of maternal death in the United States.

Madison, WI 53713
USA
Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contour
BACKGROUND: There is a paucity of evidence within the plastic surgery literature concerning risk stratification and management of patients with respect to thromboembolic disease.

Dallas, TX
USA
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembol
BACKGROUND: The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge.


USA
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
BACKGROUND: We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in preventing venous thrombosis after total knee arthroplasty.


USA
Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and p
To discuss the evidence regarding the efficacy and safety of anticoagulant prophylaxis against deep vein thrombosis (DVT) in hospitalized medical patients; to understand barriers to implementation of prophylaxis and how they can be overcome; and to have a practical approach as to which patients should and should not receive anticoagulant prophylaxis.

Hamilton, Ontario
Canada
Anticoagulation in patients with cancer: an overview of reviews
INTRODUCTION: Relative benefits and harms of anticoagulants are required for judgments regarding appropriate anticoagulation in patients with cancer.

Buffalo, NY 14215
USA
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patie
BACKGROUND: The relative benefits and harms of low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) are required for judgments regarding the appropriate perioperative thromboprophylaxis in patients with cancer.
462 Grider St
Buffalo, Ny 14215
USA
[Venous thromboses and pulmonary arterial thromboembolism in neurosurgical patients]
The paper gives the results of a study conducted in 3 groups of neurosurgical patients in the analysis of autoptic material over 15 years in order to detect pulmonary arterial thromboembolism (PATE) as a cause of postoperative death in neurosurgical patients.


Russia